Amicus pays Dimerix $30M for late-phase rare kidney disease drug
02 May 2025 //
GLOBENEWSWIRE
Dimerix, Amicus Therapeutics License Agreement for DMX-200 in US
30 Apr 2025 //
GLOBENEWSWIRE
Dimerix’s DMX-200 posts strong results in kidney disease trial
29 Jul 2020 //
BIOMELBOURNE